Connect Biopharma Holdings (CNTB) Financials

$1.24

$0.07 (5.98%)

As on 16-Sep-2026 16:28EDT

Market cap

$128 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

--

P/B Ratio

4.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	3.14	0.06	26.03	--	--	--
Cost of Revenue	--	--	0.66	0.99	1.03	--
Gross Profit	2.95	0.06	26.03	-0.99	-1.03	--
Operating Expenses	93.14	58.14	48.49	69.06	119.32	98.11
Operating Profit (EBIT)	-90.02	-58.07	-22.45	-69.06	-119.32	-98.11
Other Income	--	--	--	--	--	--
Profit before Tax	-88.15	-55.28	-15.41	-61.99	-117.79	-202.00
Provision for Tax	0.14	0.20	0.22	0.12	0.30	0.27
Profit after Tax (Net Income)	-88.39	-55.48	-15.63	-62.11	-118.09	-202.27
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-1,306.82

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	26.86	41.98	92.17	101.50	157.49	272.26
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.31	0.48	0.66	0.59	0.90	0.81
Current Liabilities	16.30	13.61	8.46	25.29	15.62	17.99
Total Liabilities	59.77	56.08	101.28	127.38	174.01	291.05

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	4.85	5.15	4.32	4.82	18.23	15.93
Current Assets	38.62	50.93	96.96	122.55	155.78	275.13
Total Assets	59.77	56.08	101.28	127.38	174.01	291.05
Total Debt*	0.60	0.69	0.18	0.47	0.43	0.13
Net Current Assets	22.32	37.32	88.50	96.71	976.12	1,639.47

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-51.21	-23.61	-47.93	-99.27	-544.93
Cash Flow from Investing Activities	--	9.82	-3.45	75.16	-83.44	-34.03
Cash from Financing Activities	--	1.09	0.23	-0.25	-0.09	1,316.10
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.47	-1.00	-0.28	-1.13	-2.15	-3.76
Cash EPS ($)	--	-0.98	-0.27	-1.11	-2.02	-3.69
Adjusted Book Value ($)	--	0.75	1.67	1.84	2.86	5.07
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.92	-0.43	-0.87	-1.80	-10.14
Free Cash Flow per Share ($)	--	-0.93	-0.44	-0.88	-1.88	-11.03

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-82.18	-16.09	-47.79	-54.89	-162.87
ROE (%)	-256.79	-82.72	-16.14	-47.96	-54.96	-162.97
ROA (%)	-115.36	-70.51	-13.67	-41.21	-50.78	-127.82
EBIT Margin (%)	-1,666.44	-86,379.69	-59.17	--	--	--
Net Margin (%)	-2,816.73	-86,687.50	-60.03	--	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	59.69	-1.00	--	--	--	--
EBIT Growth (%)	-141.61	-258.86	75.15	47.37	41.70	-70.56
Net Profit Growth (%)	-96.63	-255.00	74.84	47.41	41.62	-69.45
EPS Growth (%)	-81.00	-2.52	0.75	0.47	0.43	-0.73
Book Value Growth (%)	-66.77	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-2.83	-4.87	-1.05	-0.40	-1.37
Price / Book Value	4.84	3.74	0.83	0.64	0.30	1.02
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.19	-2.08	1.18	0.86	0.89	-0.05
Close Price ($)	2.38	2.82	1.38	1.18	0.87	5.15
High Price ($)	3.82	3.28	2.66	2.84	5.99	29.27
Low Price ($)	1.02	0.51	0.90	0.53	0.56	4.06
Market Cap ($ Cr)	128.47	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.00	0.00	0.00	0.00
Short term debt to equity ratio	0.01	0.01	0.00	0.00	0.00	0.00
Current Ratio	2.37	3.74	11.46	4.85	9.97	15.30
Quick Ratio	2.37	--	--	5.40	10.38	15.30
Interest Coverage	--	--	--	-2,695.04	-5,599.66	-29,236.21

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	93.56	251.56	4.04	--	--	--
Asset Turnover	0.04	0.00	0.23	--	--	--
Receivable days	--	3,458.46	9.84	--	--	--
Inventory Days	--	--	-7,720.45	-3,765.75	-1,139.15	--
Payable days	--	--	705.87	2,614.79	4,371.80	--
Cash Conversion Cycle	--	--	-8,416.49	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.